A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling ...
M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for ...
LGM Pharma is making strategic investments to support the growing need for high-quality domestic drug manufacturing,” “We have several prescription products in development, including both 505 (b) (2) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results